Skip to content

A clinical study to evaluate the effect of siddha medicine Bojana Kudori Mathirai in patients with Soothaga Vaayu (Polycystic Ovarian Disease)

Single centric Phase II open clinical trial in Soothaga Vaayu (Polycystic Ovarian Disease) with siddha medicine Bojana Kudori Mathirai - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105113
Enrollment
43
Registered
2026-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: BOJANA KUDORI MATHIRAl: 35 gm of Zingiber officinale, Ferula asafoetida, Zingiber officinale, Sodium chloride impura, Cuminum cyminum, Piper nigrum, purified and grinded using lemon jui

Sponsors

Dr V MAHALAKSHMI SWAATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Polysystic appearance of ovaries (Unilateral/Bilateral)

Exclusion criteria

Exclusion criteria: Previous K/C/H/O of Endocrine disease Previous K/C/H/O of any serious systemic illness

Design outcomes

Primary

MeasureTime frame
It is mainly assessed by, 1. Disappearance/reduction in the size or number of cysts in ultrasonogram(Abdomen and pelvis)Timepoint: It is mainly assessed by, 1. Disappearance/reduction in the size or number of cysts in ultrasonogram(Abdomen and pelvis)

Secondary

MeasureTime frame
It is mainly assessed by, 1. Disappearance/reduction in the size or number of cysts in ultrasonogram(Abdomen and pelvis)Timepoint: 90 days

Countries

India

Contacts

Public ContactDr K SUDHAMATHI PUSHPARAJ

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

sudhamathipushparaj@gmail.com9445118473

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026